Roschke, A. V., Lababidi, S., Tonon, G., Gehlhaus, K. S., Bussey, K., Weinstein, J. N., & Kirsch, I. R. (2005). Karyotypic “state” as a potential determinant for anticancer drug discovery. National Academy of Sciences.

Roschke, Anna V., Samir Lababidi, Giovanni Tonon, Kristen S. Gehlhaus, Kimberly Bussey, John N. Weinstein, i Ilan R. Kirsch. Karyotypic “state” As a Potential Determinant for Anticancer Drug Discovery. National Academy of Sciences, 2005.

Roschke, Anna V., et al. Karyotypic “state” As a Potential Determinant for Anticancer Drug Discovery. National Academy of Sciences, 2005.